Inventor · disambiguated record
Minghua Wang
Also filed as: WANG MINGHUA
31 granted patents·3 pending applications·264 citations·filing 2015–2021
97Inventor score
Files withFORMA THERAPEUTICS INC20VALO EARLY DISCOVERY INC8ACURX PHARMACEUTICALS LLC4VALO HEALTH INC2
Top patents by PatentIndex Score
34 records- 0197US9840491B2Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitorsFORMA THERAPEUTICS INC·Filed 2016·Granted Dec 12, 2017·22 cites·17 claims
- 0296US10377767B2Thienopyrimidinones as ubiquitin-specific protease 7 inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Aug 13, 2019·16 cites·16 claims
- 0396US10377773B2Isothiazolopyrimidinones, pyrazolopyrimidinones, and pyrrolopyrimidinones as ubiquitin-specific protease 7 inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Aug 13, 2019·18 cites·16 claims
- 0496US10000495B2Pyrrolotriazinones and imidazotriazinones as ubiquitin-specific protease 7 inhibitorsFORMA THERAPEUTICS INC·Filed 2015·Granted Jun 19, 2018·21 cites·16 claims
- 0596US9938300B2Isothiazolopyrimidinones, pyrazolopyrimidinones, and pyrrolopyrimidinones as ubiquitin-specific protease 7 inhibitorsFORMA THERAPEUTICS INC·Filed 2016·Granted Apr 10, 2018·23 cites·15 claims
- 0696US9932351B2Thienopyrimidinones as ubiquitin-specific protease 7 inhibitorsFORMA THERAPEUTICS INC·Filed 2016·Granted Apr 3, 2018·24 cites·12 claims
- 0796US9902728B2Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitorsFORMA THERAPEUTICS INC·Filed 2015·Granted Feb 27, 2018·24 cites·40 claims
- 0895US10934299B2Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitorsVALO EARLY DISCOVERY INC·Filed 2019·Granted Mar 2, 2021·7 cites·20 claims
- 0995US10377760B2Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Aug 13, 2019·17 cites·20 claims
- 1095US10351571B2Pyrrolotriazinones and imidazotriazinones as ubiquitin-specific protease 7 inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Jul 16, 2019·15 cites·17 claims
- 1194US10519129B2Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Dec 31, 2019·8 cites·21 claims
- 1294US10519127B2Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Dec 31, 2019·8 cites·24 claims
- 1394US10519130B2Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Dec 31, 2019·8 cites·21 claims
- 1494US10519128B2Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Dec 31, 2019·8 cites·19 claims
- 1594US10513507B2Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitorsFORMA THERAPEUTICS INC·Filed 2017·Granted Dec 24, 2019·9 cites·20 claims
- 1694US10513508B2Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Dec 24, 2019·8 cites·30 claims
- 1794US10508098B2Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Dec 17, 2019·8 cites·20 claims
- 1893US10906916B2Thienopyrimidinones as ubiquitin-specific protease 7 inhibitorsVALO EARLY DISCOVERY INC·Filed 2019·Granted Feb 2, 2021·4 cites·16 claims
- 1988US10836741B2Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitorsVALO EARLY DISCOVERY INC·Filed 2019·Granted Nov 17, 2020·3 cites·28 claims
- 2087US10927130B2Isothiazolopyrimidinones, pyrazolopyrimidinones, and pyrrolopyrimidinones as ubiquitin-specific protease 7 inhibitorsVALO EARLY DISCOVERY INC·Filed 2019·Granted Feb 23, 2021·4 cites·16 claims
- 2185US10981915B2Pyrrolotriazinones and imidazotriazinones as ubiquitin-specific protease 7 inhibitorsVALO EARLY DISCOVERY INC·Filed 2019·Granted Apr 20, 2021·3 cites·12 claims
- 2283US10399980B2Purinones as ubiquitin-specific protease 1 inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Sep 3, 2019·2 cites·11 claims
- 2383US10189841B2Purinones as ubiquitin-specific protease 1 inhibitorsFORMA THERAPEUTICS INC·Filed 2016·Granted Jan 29, 2019·3 cites·11 claims
- 2481US11161848B2Purinones as ubiquitin-specific protease 1 inhibitorsFORMA THERAPEUTICS INC·Filed 2019·Granted Nov 2, 2021·1 cites·26 claims
- 2576US11739071B2Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitorsVALO EARLY DISCOVERY INC·Filed 2020·Granted Aug 29, 2023·0 cites·20 claims
- 2675US12043623B2Purinones as ubiquitin-specific protease 1 inhibitorsFORMA THERAPEUTICS INC·Filed 2021·Granted Jul 23, 2024·0 cites·20 claims
- 2773US11795171B2Pyrrolotriazinones and imidazotriazinones as ubiquitin-specific protease 7 inhibitorsVALO HEALTH INC·Filed 2021·Granted Oct 24, 2023·0 cites·10 claims
- 2872US12018030B2Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitorsVALO HEALTH INC·Filed 2021·Granted Jun 25, 2024·0 cites·16 claims
- 2972US2021292337A1Thienopyrimidinones as ubiquitin-specific protease 7 inhibitorsVALO EARLY DISCOVERY INC·Filed 2021·Application pending·0 cites
- 3071US2021323978A1Isothiazolopyrimidinones, pyrazolopyrimidinones, and pyrrolopyrimidinones as ubiquitin-specific protease 7 inhibitorsVALO EARLY DISCOVERY INC·Filed 2021·Application pending·0 cites
- 3169US10723741B1DNA polymerase IIIC inhibitors and use thereofACURX PHARMACEUTICALS LLC·Filed 2019·Granted Jul 28, 2020·0 cites·11 claims
- 3269US2022112195A1DNA Polymerase IIIC Inhibitors and Use ThereofACURX PHARMACEUTICALS LLC·Filed 2021·Application pending·0 cites
- 3368US11001592B2DNA polymerase IIIC inhibitors and use thereofACURX PHARMACEUTICALS LLC·Filed 2020·Granted May 11, 2021·0 cites·17 claims
- 3467US10836772B2DNA polymerase IIIC inhibitors and use thereofACURX PHARMACEUTICALS LLC·Filed 2020·Granted Nov 17, 2020·0 cites·6 claims
Join the waitlist — get patent alerts
Get an alert when Minghua Wang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →